FDA
-
-
-
-
-
-
-
Alnylam partners with Viz.ai and American Heart Association on ATTR-CM care
-
-
-
-
-
-
-
Alnylam to Invest $250 Million to Add Enzymatic Ligation Platform to U.S. Manufacturing Facility to Meet Growing Global Demand for RNAi Therapeutics
-
-
-
-
-
-
-
Alnylam reports reduced gastrointestinal events in ATTR-CM study
-
-
-
-
-
-
-
Alnylam to start Phase 3 heart trial for blood pressure drug
-
-
-
-
-
-
-
Alnylam Pharma (ALNY) Receives EU Approval for AMVUTTRA
-
-
-
-
-
-
-
Piper Sandler: 'What Biotech Names to Own in Market Volatility'
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
-
329,618 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

